2 studies found for:    7822316 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
Condition: Resistant Solid Malignancies
Interventions: Drug: Temsirolimus;   Drug: Pegylated liposomal doxorubicin
2 Active, not recruiting Erlotinib and Temsirolimus for Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Erlotinib;   Drug: Temsirolimus

Indicates status has not been verified in more than two years